Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547 |
Resumo: | Introduction: The Brazilian Ministry of Health established the National List of Medicinal Plants of Interest to the Unified Health System (Renisus) to encourage scientific research related to a list of 71 plant species with potential to generate new productsfor the public health system. However, only 12 of these species are contemplated by the Brazilian National List of Essential Medicines (Rename) and therefore have their respective phytomedicines offered at SUS. In addition, 3 of them are not contemplated in the Brazilian Pharmacopoeia. Objective: This work aims to indicate the possibility of using the available references to elaborate and include the missing monographs in the Brazilian Pharmacopoeia; as well as to assess whether the main government policy to encourage research in the area influenced Brazilian scientific production considering the studied profile. Method: A longitudinal retrospective study was carried out using the Web of Science and Scopus databases regarding the quality control of the 12 plant species contemplated in the Rename by different analytical techniques considering the pre andpost-Renisus periods (pre and post-2010). Results: All evaluated species presented scientific articles describing analytical methods to determine their constituents. Among the evaluated species, 67% had low individual nominal growth (≤ 8 articles) in the pre and post Renisus periods, while the rest showed greater growth (≥ 19 articles). Conclusions: There are available references in the literature with potential analytical methods for the elaboration of the missing pharmacopoeial monographs in the Brazilian compendium. However, the incentive policies may not have had significantly influenced the studied fraction of the Brazilian scientific production. |
id |
FIOCRUZ-9_6aef378cba5f09791fe98cbf2de53fc5 |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/1547 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential MedicinesProdução científica de 2010 a 2018 sobre o controle de qualidade de espécies vegetais incluídas na Relação Nacional de Medicamentos EssenciaisPlantas medicinaisFitoterápicosAnálise bibliométricaSistema Único de SaúdeRENISUSMedicinal plantsPhytomedicinesBibliometric analysisBrazilian Unified Health SystemRENISUSIntroduction: The Brazilian Ministry of Health established the National List of Medicinal Plants of Interest to the Unified Health System (Renisus) to encourage scientific research related to a list of 71 plant species with potential to generate new productsfor the public health system. However, only 12 of these species are contemplated by the Brazilian National List of Essential Medicines (Rename) and therefore have their respective phytomedicines offered at SUS. In addition, 3 of them are not contemplated in the Brazilian Pharmacopoeia. Objective: This work aims to indicate the possibility of using the available references to elaborate and include the missing monographs in the Brazilian Pharmacopoeia; as well as to assess whether the main government policy to encourage research in the area influenced Brazilian scientific production considering the studied profile. Method: A longitudinal retrospective study was carried out using the Web of Science and Scopus databases regarding the quality control of the 12 plant species contemplated in the Rename by different analytical techniques considering the pre andpost-Renisus periods (pre and post-2010). Results: All evaluated species presented scientific articles describing analytical methods to determine their constituents. Among the evaluated species, 67% had low individual nominal growth (≤ 8 articles) in the pre and post Renisus periods, while the rest showed greater growth (≥ 19 articles). Conclusions: There are available references in the literature with potential analytical methods for the elaboration of the missing pharmacopoeial monographs in the Brazilian compendium. However, the incentive policies may not have had significantly influenced the studied fraction of the Brazilian scientific production.Introdução: O Ministério da Saúde elaborou a Relação Nacional de Plantas Medicinais de Interesse ao Sistema Único de Saúde (Renisus) para incentivar a pesquisa científica de 71 espécies vegetais com potencial para gerar produtos para o Sistema Único de Saúde. Destas, 12 constam na Relação Nacional de Medicamentos Essenciais (Rename) e, portanto, têmseus respectivos fitoterápicos ofertados no sistema público. Entretanto, três ainda não apresentam monografias na Farmacopeia Brasileira. Objetivo: Avaliar quantitativamente a produção científica sobre o controle de qualidade das 12 espécies da Rename, demonstrar a possibilidade de utilização das referências já disponíveis na elaboração e inclusão das monografias ainda não contempladas no compêndio nacional e avaliar se a principal política governamental de incentivo da área influenciou a produção científica brasileira considerando o recorte estudado. Método: O levantamento dos dados foi realizado a partir de um estudo longitudinal retrospectivo, considerando o controle de qualidade das 12 espécies vegetais da Rename por diferentes técnicas analíticas nos períodos pré e pós-Renisus (pré e pós-2010), utilizando as bases de dados Web of Science e Scopus. Resultados: Todas as espécies avaliadas apresentaram artigos científicos descrevendo métodos analíticos para a determinação de seus constituintes. Considerando a produção científica brasileira, 67% das espécies vegetais apresentaram baixo crescimento nominal individual (≤ oito artigos) no período posterior à promulgação da Renisus, enquanto orestante apresentou maior crescimento (≥ 19 artigos). Conclusões: As espécies ainda não contempladas na Farmacopeia Brasileira apresentaram referências na literatura com potenciais métodos analíticos para elaboração de futuras monografias farmacopeicas. Entretanto, as políticas de incentivo podem não ter influenciado significativamente a fração estudada da produção científica brasileira.Instituto Nacional de Controle de Qualidade em Saúde2021-05-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/154710.22239/2317-269x.01547Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 2 (2021): May; 21-27Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 2 (2021): Puede; 21-27Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 2 (2021): Maio; 21-272317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1243https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1359Copyright (c) 2020 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessRodrigues, Lucas OliveiraMourão, Samanta CardozoGouvêa, Marcos Martins2023-06-27T15:13:26Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1547Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:13:26Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines Produção científica de 2010 a 2018 sobre o controle de qualidade de espécies vegetais incluídas na Relação Nacional de Medicamentos Essenciais |
title |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines |
spellingShingle |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines Rodrigues, Lucas Oliveira Plantas medicinais Fitoterápicos Análise bibliométrica Sistema Único de Saúde RENISUS Medicinal plants Phytomedicines Bibliometric analysis Brazilian Unified Health System RENISUS |
title_short |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines |
title_full |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines |
title_fullStr |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines |
title_full_unstemmed |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines |
title_sort |
Scientific production from 2010 to 2018 about the quality control of plant species included in the Brazilian National List of Essential Medicines |
author |
Rodrigues, Lucas Oliveira |
author_facet |
Rodrigues, Lucas Oliveira Mourão, Samanta Cardozo Gouvêa, Marcos Martins |
author_role |
author |
author2 |
Mourão, Samanta Cardozo Gouvêa, Marcos Martins |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Rodrigues, Lucas Oliveira Mourão, Samanta Cardozo Gouvêa, Marcos Martins |
dc.subject.por.fl_str_mv |
Plantas medicinais Fitoterápicos Análise bibliométrica Sistema Único de Saúde RENISUS Medicinal plants Phytomedicines Bibliometric analysis Brazilian Unified Health System RENISUS |
topic |
Plantas medicinais Fitoterápicos Análise bibliométrica Sistema Único de Saúde RENISUS Medicinal plants Phytomedicines Bibliometric analysis Brazilian Unified Health System RENISUS |
description |
Introduction: The Brazilian Ministry of Health established the National List of Medicinal Plants of Interest to the Unified Health System (Renisus) to encourage scientific research related to a list of 71 plant species with potential to generate new productsfor the public health system. However, only 12 of these species are contemplated by the Brazilian National List of Essential Medicines (Rename) and therefore have their respective phytomedicines offered at SUS. In addition, 3 of them are not contemplated in the Brazilian Pharmacopoeia. Objective: This work aims to indicate the possibility of using the available references to elaborate and include the missing monographs in the Brazilian Pharmacopoeia; as well as to assess whether the main government policy to encourage research in the area influenced Brazilian scientific production considering the studied profile. Method: A longitudinal retrospective study was carried out using the Web of Science and Scopus databases regarding the quality control of the 12 plant species contemplated in the Rename by different analytical techniques considering the pre andpost-Renisus periods (pre and post-2010). Results: All evaluated species presented scientific articles describing analytical methods to determine their constituents. Among the evaluated species, 67% had low individual nominal growth (≤ 8 articles) in the pre and post Renisus periods, while the rest showed greater growth (≥ 19 articles). Conclusions: There are available references in the literature with potential analytical methods for the elaboration of the missing pharmacopoeial monographs in the Brazilian compendium. However, the incentive policies may not have had significantly influenced the studied fraction of the Brazilian scientific production. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-05-31 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547 10.22239/2317-269x.01547 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547 |
identifier_str_mv |
10.22239/2317-269x.01547 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1243 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1547/1359 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 2 (2021): May; 21-27 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 2 (2021): Puede; 21-27 Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 2 (2021): Maio; 21-27 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042045930438656 |